Interestingly, we observed significant activation of T cells in both the primary tumor and lungs, characterized by elevated inducible T-cell costimulator (ICOS+) and CD25+ cells, with no differences in the number of regulatory T cells (Tregs) (Figs 6A and S6A–D). This evidence concerns the gene ICOS and neoplasm.